Contemporary Clinical Trials Communications (Dec 2018)

Central masked adjudication of stroke diagnosis at trial entry offered no advantage over diagnosis by local clinicians: Secondary analysis and simulation

  • Peter J. Godolphin,
  • Trish Hepburn,
  • Nikola Sprigg,
  • Liz Walker,
  • Eivind Berge,
  • Ronan Collins,
  • John Gommans,
  • George Ntaios,
  • Stuart Pocock,
  • Kameshwar Prasad,
  • Joanna M. Wardlaw,
  • Philip M. Bath,
  • Alan A. Montgomery

Journal volume & issue
Vol. 12
pp. 176 – 181

Abstract

Read online

Background: Central adjudication of stroke type is commonly implemented in large multicentre clinical trials. We investigated the effect of central adjudication of diagnosis of stroke type at trial entry in the Efficacy of Nitric Oxide in Stroke (ENOS) trial. Methods: ENOS recruited patients with acute ischaemic or haemorrhagic stroke, and diagnostic adjudication was carried out using cranial scans. For this study, diagnoses made by local site clinicians were compared with those by central, masked adjudicators using kappa statistics. The trial primary analysis and subgroup analysis by stroke type were re-analysed using stroke diagnosis made by local clinicians, and simulations were used to assess the impact of increased non-differential misclassification and subgroup effects. Results: Agreement on stroke type (Ischaemic, Intracerebral Haemorrhage, Unknown stroke type, No-stroke) was high (κ = 0.92). Adjudication of stroke type had no impact on the primary outcome or subgroup analysis by stroke type. With misclassification increased to 10 times the level observed in ENOS and a simulated subgroup effect present, adjudication would have affected trial conclusions. Conclusions: Stroke type at trial entry was diagnosed accurately by local clinicians in ENOS. Adjudication of stroke type by central adjudicators had no measurable effect on trial conclusions. Diagnostic adjudication may be important if diagnosis is complex and a treatment-diagnosis interaction is expected. Keywords: Adjudication, Diagnosis, Clinical trial, Stroke